17
Tetanus Toxoid MICS3 Data Analysis and Report Writing Workshop

Tetanus Toxoid MICS3 Data Analysis and Report Writing Workshop

Embed Size (px)

Citation preview

Page 1: Tetanus Toxoid MICS3 Data Analysis and Report Writing Workshop

Tetanus Toxoid

MICS3 Data Analysis and Report Writing Workshop

Page 2: Tetanus Toxoid MICS3 Data Analysis and Report Writing Workshop

International Goals & Targets

MDG 5: Reduce by three quarters the maternal mortality ratio

Strategy: Elimination of maternal and neonatal tetanus

Target: Reduce incidence of neonatal tetanus to less than 1 case of neonatal tetanus per 1000 live births in every district

Page 3: Tetanus Toxoid MICS3 Data Analysis and Report Writing Workshop

International Goals & Targets

By 2005, Reduction in infant and under-five mortality rate by at least 1/3, in pursuit of the goal of reducing it by 2/3 by 2015

Eliminate maternal and neonatal tetanus by 2005

Page 4: Tetanus Toxoid MICS3 Data Analysis and Report Writing Workshop

Background

• Caused by tetanus spores, a bacteria found everywhere in the environment

• Transmission occurs when there is contact with broken skin such as an infant’s umbilical cord

• Poverty, poor hygiene and limited access to health services increase the risk for transmission during childbirth

Page 5: Tetanus Toxoid MICS3 Data Analysis and Report Writing Workshop

Background

Prevention is possible by:

1. Immunization of pregnant women with at least 2 doses of tetanus toxoid vaccine (TT2+), passing protection to the newborn for up to first two months of life

2. Immunization of women of childbearing age who live in areas of high risk for transmission (delivery of immunizations usually through campaigns)

3. Promotion of clean delivery and cord care practices

Page 6: Tetanus Toxoid MICS3 Data Analysis and Report Writing Workshop

BackgroundDeaths of children by cause for vaccine preventable diseases

(As of March 2004; source WHO)

Cause 2002

  Under 5 Over 5  

Diphtheria 4,000 1,000  

Measles 540,000 71,000  

Poliomyelitis .. ..  

Tetanus (excluding NT) 18,000 15,000  

Neonatal Tetanus 180,000 ..  

Pertussis 294,000 …  

Yellow Fever 15,000 15,000  

Haemophilus Influenzae B 413,000 …  

Total 1,464,000 102,000  

Page 7: Tetanus Toxoid MICS3 Data Analysis and Report Writing Workshop

Note: The boundaries and the names shown and the designations used on these maps do not imply official endorsement or acceptance by the United Nations.

MNT not eliminated

Countries with TT campigns

MNT eliminated * includes Timor-Leste

1997 2000 2002

248,000

200,000180,000

Neonatal Tetanus death reduction

Situation of Maternal and Neonatal Tetanus(Remains a problem in 48 countries)

Page 8: Tetanus Toxoid MICS3 Data Analysis and Report Writing Workshop

Indicator

Neonatal tetanus protection

(protection at birth against tetanus)

Numerator Number of mothers of live births in the previous year with at least two doses of TT within appropriate interval prior to infant’s birth

Denominator Total number of women surveyed aged 15-49 years with a birth in the year preceding the survey

Page 9: Tetanus Toxoid MICS3 Data Analysis and Report Writing Workshop

Methodological issues

-Data collected for all births during the 2 years before the survey – indicator includes only those during the last one year-Complex algorithm for the estimation of the numerator

Page 10: Tetanus Toxoid MICS3 Data Analysis and Report Writing Workshop

Methodological issues

o two TT doses during the pregnancy (TT3>=2)o one TT dose during the pregnancy and at least

one TT dose prior to the pregnancy (TT3=1 AND TT6>=1)

o at least two TT doses prior to the pregnancy of which the last dose was less than 3 years before the birth

o with 3 doses within the 5 years before the pregnancy

o with 4 doses with the last dose less than 10 years before the pregnancy

o with 5 doses or more ever (TT6>=5).

Page 11: Tetanus Toxoid MICS3 Data Analysis and Report Writing Workshop

Country data – CEE/CIS

Neonatal tetanus protection (%), 2004

Turkey 41%

Page 12: Tetanus Toxoid MICS3 Data Analysis and Report Writing Workshop

Country data – Eastern and Southern Africa

Neonatal tetanus protection (%),2004

62

45

45

46

53

55

60

60

61

62

67

70

70

70

75

76

83

90

0 10 20 30 40 50 60 70 80 90 100

Eastern and Southern Africa

Burundi

Ethiopia

Comoros

Uganda

Madagascar

Mozambique

Somalia

South Africa

Eritrea

Namibia

Kenya

Malawi

Zimbabwe

Angola

Rwanda

Zambia

Tanzania

Page 13: Tetanus Toxoid MICS3 Data Analysis and Report Writing Workshop

Country data – West and Central Africa

Neonatal tetanus protection (%), 2004

5733

354040

4243

455051

5658

6061

6565

6970

757677

85

0 10 20 30 40 50 60 70 80 90 100

West and Central AfricaMauritania

LiberiaEquitorial Guinea

ChadCentral African

NigerGabon

MaliNigeria

Guinea-BissauCongo Dem. Rep.

CameroonTogo

Burkina FasoCongoBenin

GhanaCôte d’IvoireSierra Leone

GuineaSenegal

Page 14: Tetanus Toxoid MICS3 Data Analysis and Report Writing Workshop

Country data – MENA

Neonatal tetanus protection (%), 2004

21

37

70

71

0 20 40 60 80 100

Yemen

Sudan

Iraq

Egypt

Page 15: Tetanus Toxoid MICS3 Data Analysis and Report Writing Workshop

Country data – LAC

Neonatal tetanus protection (%), 2004

Haiti 52%

Page 16: Tetanus Toxoid MICS3 Data Analysis and Report Writing Workshop

Country data – South Asia

Neonatal tetanus protection (%), 2004

70

35

42

45

45

80

0 10 20 30 40 50 60 70 80 90 100

South Asia

Afghanistan

Nepal

Bangladesh

Pakistan

India

Page 17: Tetanus Toxoid MICS3 Data Analysis and Report Writing Workshop

Country data – East Asia and the Pacific

Neonatal tetanus protection (%), 2004

10

30

51

54

70

85

85

0 10 20 30 40 50 60 70 80 90 100

Papua New Guinea

Lao PDR

Cambodia

Indonesia

Philippines

Myanmar

Vietnam